GGrantIndex
← Leaderboards

Hao Shen

University Of Pennsylvania

$13,004,982
Attributed
$18,298,714
Total exposure
12
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.2M · FY200520
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20

Funding mix

By agency

NIH$18,298,714 · 12

By mechanism

R01$13,100,154 · 4
U19$2,306,932 · 2
R21$1,602,483 · 4
R41$865,145 · 1
R56$424,000 · 1

Top collaborators

Most similar at University Of Pennsylvania

Same institution · by research overlap

Others in their field

Top investigators on “Infection

Research focus

InfectionVirus DiseasesAntigensBacteriaResponseImmune ResponseInfluenzavirusImmunityEnvironmentPathogenIn VivoViralT-LymphocyteVaccinesCytokineImmuneProductionGene ExpressionBacterial PneumoniaCellsDefectMolecularBasePlay

Grant awards (43)

Treating chronic viral infection by epigenetic reprogramming of exhausted CD8 T cells$539,449
R01 · FY2020 · AI · contact PI
Treating chronic viral infection by epigenetic reprogramming of exhausted CD8 T cells$545,617
R01 · FY2019 · AI · contact PI
Treating chronic viral infection by epigenetic reprogramming of exhausted CD8 T cells$545,617
R01 · FY2018 · AI · contact PI
Regenerative therapy for lung infection by S. pneumoniae$200,293
R21 · FY2018 · AI · contact PI
Development of a novel adjuvant for vaccine sparing$1,248,398
R01 · FY2017 · AI
Treating chronic viral infection by epigenetic reprogramming of exhausted CD8 T cells$550,512
R01 · FY2017 · AI · contact PI
Regenerative therapy for lung infection by S. pneumoniae$255,815
R21 · FY2017 · AI · contact PI
Development of a novel adjuvant for vaccine sparing$1,250,865
R01 · FY2016 · AI
Mechanisms of Haemophilus influenzae pathogenesis in the lung$379,020
R01 · FY2016 · AI
Development of a novel adjuvant for vaccine sparing$1,197,649
R01 · FY2015 · AI
Mechanisms of Haemophilus influenzae pathogenesis in the lung$379,020
R01 · FY2015 · AI
Development of a novel adjuvant for vaccine sparing$1,203,147
R01 · FY2014 · AI
Mechanisms of Haemophilus influenzae pathogenesis in the lung$392,253
R01 · FY2014 · AI
Development of a novel adjuvant for vaccine sparing$1,393,822
R01 · FY2013 · AI
Mechanisms of Haemophilus influenzae pathogenesis in the lung$383,403
R01 · FY2013 · AI
The Impact of Bacterial Co-Infectin on Respiratory Virus-Specific T cell Response$318,793
U19 · FY2013 · AI · contact PI
Microbiology Core$128,773
U19 · FY2013 · AI · contact PI
The Impact of Bacterial Co-Infectin on Respiratory Virus-Specific T cell Response$333,245
U19 · FY2012 · AI · contact PI
Mechanisms of Haemophilus influenzae pathogenesis in the lung$237,927
R01 · FY2012 · AI
Microbiology Core$191,728
U19 · FY2012 · AI · contact PI
Mechanisms of Haemophilus influenzae pathogenesis in the lung$424,000
R56 · FY2011 · AI
The Impact of Bacterial Co-Infectin on Respiratory Virus-Specific T cell Response$322,188
U19 · FY2011 · AI · contact PI
Microbiology Core$162,880
U19 · FY2011 · AI · contact PI
The Impact of Bacterial Co-Infectin on Respiratory Virus-Specific T cell Response$334,316
U19 · FY2010 · AI · contact PI
Molecular basis of defective CD8 T cells during chronic viral infection$236,250
R21 · FY2010 · AI · contact PI
Microbiology Core$172,643
U19 · FY2010 · AI · contact PI
The Impact of Bacterial Co-Infectin on Respiratory Virus-Specific T cell Response$342,366
U19 · FY2009 · AI · contact PI
Molecular basis of defective CD8 T cells during chronic viral infection$196,875
R21 · FY2009 · AI · contact PI
Cellular Immune Surveillance of Intracellular bacteria$313,087
R01 · FY2008 · AI · contact PI
New attenuated anthrax vaccine$478,807
R41 · FY2007 · AI · contact PI
Cellular Immune Surveillance of Intracellular bacteria$319,151
R01 · FY2007 · AI · contact PI
New attenuated anthrax vaccine$386,338
R41 · FY2006 · AI · contact PI
Cellular Immune Surveillance of Intracellular bacteria$329,131
R01 · FY2006 · AI · contact PI
Cellular Immune Surveillance of Intracellular bacteria$337,051
R01 · FY2005 · AI
Cellular Immune Surveillance of Intracellular bacteria$337,051
R01 · FY2004 · AI
COMPARTMENTALIZATION OF BACTERIAL ANTIGENS$272,130
R01 · FY2003 · AI
Modulation of T cell Responses by Ebola Glycoprotein$237,750
R21 · FY2003 · AI
COMPARTMENTALIZATION OF BACTERIAL ANTIGENS$323,943
R01 · FY2002 · AI
Modulation of T cell Responses by Ebola Glycoprotein$237,750
R21 · FY2002 · AI
COMPARTMENTALIZATION OF BACTERIAL ANTIGENS$316,567
R01 · FY2001 · AI
COMPARTMENTALIZATION OF BACTERIAL ANTIGENS$249,034
R01 · FY2000 · AI
NEW STRATEGIES FOR BACTERIAL DELIVERY OF DNA VACCINES$237,750
R21 · FY2000 · AI
COMPARTMENTALIZATION OF BACTERIAL ANTIGENS$56,310
R01 · FY2000 · AI